Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 6 consecutive quarters of double digit growth.
Click here to learn more ›

September 2019

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results

Press Releases / By

Teleconference and Webcast to be held on September 12, 2019 Sep 12, 2019, 07:30 ET CRANBURY, N.J., Sept. 12, 2019 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, whose product candidates are targeted, receptor-specific …

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results Read More »

Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019

Press Releases / By

Sep 11, 2019, 12:00 ET CRANBURY, N.J., Sept. 11, 2019 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2019 operating results on Thursday, September 12, 2019 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by …

Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019 Read More »

Scroll to Top